GlassScriptPhysician profile
Rita M Dixon
NPI 1215180278
$1,771.44
in general payments reported to CMS, 2019-2025
13 companies · $246 in 2025
The $246 reported for 2025 was more than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $554 · 2022: $543 · 2023: $328 · 2024: $101 · 2025: $246.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $675.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $674.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shionogi INC | $224.12 | 2021-2022 | |
| Teva Pharmaceuticals USA, INC. | $218.26 | 2022-2025 | Austedo Xr |
| Cvrx, INC. | $212.82 | 2022-2023 | Barostim Neo System |
| Amgen INC. | $199.75 | 2021-2024 | Uplizna |
| Novo Nordisk INC | $184.48 | 2021-2023 | Ozempic, Rybelsus |
| Astrazeneca Pharmaceuticals LP | $164.31 | 2022 | |
| Boston Scientific Corporation | $138.48 | 2021-2025 | Watchman Flx |
| Madrigal Pharmaceuticals | $131.02 | 2025 | Rezdiffra |
| Convatec INC. | $129.00 | 2023 | |
| Sanofi-Aventis U.S. LLC | $91.53 | 2021 | |
| Cmp Pharma, INC. | $46.13 | 2021 | |
| Cardiva Medical, INC. | $16.80 | 2023 | Cardiva Vascade Mvp Vvcs 6-12f |
| Abbott Laboratories | $14.74 | 2025 | Amplatzer Piccolo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rita Dixon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.